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Introduction: It is not clear whether patients with sinus rhythm and reduced left ventricular function should be
treated with anticoagulation therapy during or after treatment for heart failure.
Case presentation: A 67-year-old Japanese man was hospitalized at our institution with heart failure due to dilated
cardiomyopathy. On day after discharge, he developed cerebral infarction and showed persistence of multiple left
ventricular thrombi. His paralysis completely improved at 2 days after edaravone and heparin administration; however,
his left visual field defect persisted.
Conclusion: Patients in sinus rhythm with reduced left ventricular function might benefit from anticoagulation therapy
during treatment for heart failure.
Keywords: Left ventricular thrombi, Anticoagulation therapy, Dilated cardiomyopathy, Cerebral infarctionIntroduction
We occasionally encounter patients who develop cere-
bral infarction during treatment for heart failure. Em-
bolic events are estimated to occur in 4% of patients
with dilated cardiomyopathy who have a left ventricular
ejection fraction (LVEF) ≤35% [1]. Further, the incidence
of LV thrombus in patients with dilated cardiomyopathy
and sinus rhythm is 13%, and the clot is located in the
left atrial appendage in 68% of these cases [2]. Although
guidelines state [3] that patients with atrial fibrillation
should be treated with anticoagulation therapy, the ben-
efits of warfarin for patients with heart failure in sinus
rhythm have yet to be established [4]. Indeed, the re-
duced risk of ischemic stroke in response to warfarin is
offset by a risk of hemorrhage in patients with reduced
LVEF [5]. Therefore, it is not clear whether patients with
sinus rhythm and reduced LV function should be treated
with anticoagulation therapy during or after treatment
for heart failure. In this report, we describe a case of a
patient with hypertensive cardiomyopathy and in sinus* Correspondence: mine@hyo-med.ac.jp
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to LV thrombi after treatment for heart failure.
Case presentation
A 67-year-old Japanese man was hospitalized at our in-
stitution with heart failure due to dilated cardiomyop-
athy. He was not taking any medications and had a
history of mild diabetes mellitus. He was discharged
after 1 week of treatment with vasodilators and diuretics.
Electrocardiographic monitoring during his hospitalization
showed sinus rhythm.
On the day after discharge, the patient presented to
our emergency unit with left-limb paresis and left visual
field defect. His medications at that time consisted of
bisoprolol, enalapril, digoxin and metformin. A physical
examination showed that his blood pressure was 119/
67mmHg, heart rate was 60 beats/min and his respira-
tory rate was 10 breaths/min. He was alert, and an elec-
trocardiogram obtained upon admission showed LV
hypertrophy, premature ventricular contractions and sinus
rhythm with a heart rate of 57 beats/min (Figure 1). A
chest X-ray showed cardiomegaly, and laboratory testing
indicated high plasma levels of D-dimer (3.9μg/L) and
brain natriuretic peptide (834pg/ml) and elevated trans-
aminases (aspartate aminotransferase, 38IU/L; alanined. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 Electrocardiogram obtained upon admission.
Figure 2 Brain magnetic resonance imaging scans show multiple cerebral infarctions.
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aging showed multiple cerebral infarctions in the occipi-
tal lobe, corona radiata and left frontal lobe (Figure 2).
Echocardiograms indicated LV dysfunction, a LVEF of
27%, a LV end-diastolic diameter of 66mm and two mo-
bile thrombi at the basal septum and apical inferior por-
tions of the left ventricle (Figure 3, Additional file 1).
His paralysis improved at 2 days after edaravone and
heparin administration; however, his left visual field
defect persisted. After 6 days of heparin therapy, the pa-
tient was initiated on warfarin, which led to disappear-
ance of the two mobile left ventricle clots. No evidence
of embolism was seen during treatment. We conclude
that this patient had multiple cerebral infarctions due to
LV thrombi immediately after treatment for heart failure.Figure 3 Short-axis view echocardiograms. Arrows point to two mobileThese observations highlight that LV thrombi can occur
in patients in sinus rhythm who have reduced LV func-
tion and are undergoing treatment for heart failure. For-
tunately for our patient, his thrombi disappeared after
initiation of anticoagulation therapy.
Discussion
There are several reports of multiple LV thrombi in pa-
tients with LV noncompaction [6], arrhythmogenic right
ventricular cardiomyopathy [7] and dilated cardiomyop-
athy [8,9]. However, persistence of multiple thrombi in
the left ventricle in a patient with dilated cardiomyop-
athy after stroke is extremely rare.
Anticoagulant therapy (for example, warfarin, heparin,
dabigatran) is used for the treatment of intracardiacthrombi.
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for patients with reduced LV function and in sinus
rhythm remains controversial. The benefits of warfarin
for patients in sinus rhythm have not been established
for those with heart failure [4]. No significant overall
difference was observed in mortality, intracereberal
hemorrhage or ischemic stroke when the use of warfarin
versus aspirin was compared in patients with reduced
LVEF [5]. It is not clear whether anticoagulant therapy is
needed in patients with reduced LV function and heart
failure. In one study, elderly patients presenting with
acute ischemic stroke were found to have high plasma
osmolality levels and showed dehydration [11]. Dehydra-
tion after acute ischemic stroke is strongly independently
associated with venous thromboembolism [12]. In our
patient, LV thrombi formed during treatment for heart
failure and resulted in cerebral infarction. Because coagu-
lability may be enhanced by the administration of di-
uretics, the use of anticoagulants during treatment of our
patient for heart failure might have prevented his cerebral
infarction. Therefore, we reason that patients in sinus
rhythm and with reduced LV function might benefit from
anticoagulation therapy during treatment for heart fail-
ure. However, there are no guidelines which recommend
the use of anticoagulants in heart failure during treat-
ment. It is necessary to study the incidence of cerebral
infarction and evaluate dehydration during treatment in
patients with heart failure.
Conclusion
In this report, we describe a case of a patient with di-
lated cardiomyopathy who had persistent multiple LV
thrombi after experiencing a stroke. This finding sug-
gests patients in sinus rhythm with reduced LV function
might benefit from anticoagulation therapy during treat-
ment for heart failure, but review of additional cases is
needed to validate this conclusion.
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